The Model of PPARγ-Downregulated Signaling in Psoriasis

The Model of PPARγ-Downregulated Signaling in Psoriasis

Interactions of genes in intersecting signaling pathways, as well as environmental influences, are required for the development of psoriasis. Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor and transcription factor which inhibits the expression of many proinflammatory...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vladimir Sobolev, Anastasia Nesterova, Anna Soboleva, Evgenia Dvoriankova, Anastas Piruzyan, Dzerassa Mildzikhova, Irina Korsunskaya, Oxana Svitich
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2020/6529057
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2010-01-01)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)

PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung
by: Virender K. Rehan, et al.
Published: (2012-01-01)

Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer
by: Sakshi Sikka, et al.
Published: (2012-01-01)

Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
by: Anna Leonardini, et al.
Published: (2009-01-01)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
by: A. Belfiore, et al.
Published: (2009-01-01)

Signaling Crosstalk between PPARγ and BMP2 in Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2012-01-01)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

PPARγ and Its Role in Cardiovascular Diseases
by: Mini Chandra, et al.
Published: (2017-01-01)

Therapeutic Implications of PPARγ in Cardiovascular Diseases
by: Hiroshi Hasegawa, et al.
Published: (2010-01-01)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)

Resolving the Two “Bony” Faces of PPAR-γ
by: Beata Lecka-Czernik, et al.
Published: (2006-01-01)

Therapeutic Implications of PPARγ in Human Osteosarcoma
by: Eric R. Wagner, et al.
Published: (2010-01-01)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)

To Live or to Die: Prosurvival Activity of PPARγ in Cancers
by: Y. Lynn Wang, et al.
Published: (2008-01-01)

Fine-Tuning Reception in the Bone: PPARγ and Company
by: Z. Elizabeth Floyd, et al.
Published: (2006-01-01)

PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01)

Identification of Bexarotene as a PPARγ Antagonist with HDX
by: David P. Marciano, et al.
Published: (2015-01-01)

PPARγ in Bacterial Infections: A Friend or Foe?
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

Protective Actions of PPAR-γ Activation in Renal Endothelium
by: Peter E. Westerweel, et al.
Published: (2008-01-01)

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation
by: Amanda Croasdell, et al.
Published: (2015-01-01)

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
by: Alice J. Kroker, et al.
Published: (2015-01-01)

Solution Structures of PPARγ2/RXRα Complexes
by: Judit Osz, et al.
Published: (2012-01-01)

PPARγ as a Novel Therapeutic Target in Lung Cancer
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01)

The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis
by: Jong-Min Lee, et al.
Published: (2012-01-01)

Nitric Oxide Mediates Inflammation in Type II Diabetes Mellitus through the PPARγ/eNOS Signaling Pathway
by: Hua Guo, et al.
Published: (2020-01-01)

RNA N6‐Methyladenosine‐Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN‐γ Signaling in Gastric Cancer
by: Dongjun Jang, et al.
Published: (2025-01-01)

The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells
by: Mohd Nor Norazmi, et al.
Published: (2012-01-01)

The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
by: Lena Serghides
Published: (2012-01-01)

PPAR-γ Regulates Trophoblast Differentiation in the BeWo Cell Model
by: Khrystyna Levytska, et al.
Published: (2014-01-01)

The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
by: Kimberly A. Placzkowski, et al.
Published: (2008-01-01)

A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer
by: Xiao Yi Yang, et al.
Published: (2008-01-01)

Structural Features and Transcriptional Activity of Chicken PPARs (α, β, and γ)
by: Ichiro Takada, et al.
Published: (2013-01-01)

Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists
by: Antonietta Bernardo, et al.
Published: (2008-01-01)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
by: Jessica Mwinyi, et al.
Published: (2012-01-01)

Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice
by: Jie Yan, et al.
Published: (2019-01-01)

Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
by: Utpal Sen, et al.
Published: (2010-01-01)